new YORK (Reuters Health) – men who are treated
for prostate cancer they would suffer many side effects even
a decade after treatment, reveals a new study.
a team of researchers found that more than 500 men with
cancer, including those who are detected with regular, pesquisas
had worse sexual function and more problems to control the
bladder 10 years after therapy than a group of men without
disease.
this would seem something just before the screening and treatment
of a cancer. but the issue is complicated: cancer of
prostate is slow growth and perhaps never would threaten the
life of the patient.
in addition, many studies could not prove that the
analysis of PSA in blood is saving lives. why, the
Special Commission of United States preventive services
(USPSTF(, by its English name) does not recommend screening of the
cancer prostate.
with the benefits of control of routine in doubt, the
treatment of adverse effects becomes more important.
“reality is that, now, the decision to have the
research and initiate a treatment is individual”, said
Kathryn L. Taylor, the Integral Center of the Lombardi Cancer of the
Georgetown University, in Washington.
“And this study does not answer those questions individually,”
said the lead author of the study, published in the Journal of
Clinical Oncology.
but argued that the findings provide them to the
men more information about side effects of the
in the long term, prostate cancer treatment either
surgery, radiation or hormone therapy.
< p> Up to 10 years after treatment, more than 95 per cent
of patients had some degree of sexual dysfunction and the
half had developed symptoms urinals.
these results suggest that the cause would not be only the
Aging, according to the information that had the team of
Taylor of the men who had participated in a study about
screening of prostate cancer.
team could compare to 269 men who had them
detected the disease with the research and had started a
treatment, with 260 men without the disease. when considering the
age, State of health and other factors, the treated group
had lost function sexual and urinary tract in the 10 years
after diagnosis.
the pattern remained in participants who had not
< p> die Forschung durchgeführt, und das hatte oder nicht erhalten eine Diagnose
e begann die Behandlung.
all dies für Taylor, legt nahe, dass das Problem in befinden würde
Behandlung von Prostatakrebs oder, vielleicht, teilweise in
Krebs. “wichtig ist, dass die Gruppe (mit Krebs der
Prostata) war schlimmer”, bekannter. und das ist für das Team, etwas
, die Männer sollten nicht vergessen, bei der Entscheidung über die Forschung
von Krebs.
Quelle: Journal of Clinical Oncology, online 25. Juni von der
2012